Prescription OxyContin abuse among patients entering addiction treatment.
about
Understanding the rural-urban differences in nonmedical prescription opioid use and abuse in the United StatesTypologies of prescription opioid use in a large sample of adults assessed for substance abuse treatmentRisk factors for incident nonmedical prescription opioid use and abuse and dependence: results from a longitudinal nationally representative sample.Gender differences in risk factors for aberrant prescription opioid useStrategies to prevent opioid misuse, abuse, and diversion that may also reduce the associated costs.Gender and prescription opioids: findings from the National Survey on Drug Use and HealthTrends in prescribed opioid therapy for non-cancer pain for individuals with prior substance use disordersScreening, brief interventions, referral to treatment (SBIRT) for illicit drug and alcohol use at multiple healthcare sites: comparison at intake and 6 months laterAge differences in heroin and prescription opioid abuse among enrolees into opioid treatment programsComparative profiles of men and women with opioid dependence: results from a national multisite effectiveness trial.Oxycodone abuse in New York City: characteristics of intravenous and intranasal users.Prescription drug abuse: epidemiology, regulatory issues, chronic pain management with narcotic analgesicsAddiction to prescription opioids: characteristics of the emerging epidemic and treatment with buprenorphineAbuse-deterrent formulations, an evolving technology against the abuse and misuse of opioid analgesics.A Randomized, Double-Blind, Double-Dummy Study to Evaluate the Intranasal Human Abuse Potential and Pharmacokinetics of a Novel Extended-Release Abuse-Deterrent Formulation of OxycodoneEvaluation of ongoing oxycodone abuse among methadone-maintained patientsUpdate on prescription extended-release opioids and appropriate patient selection.Brief buprenorphine detoxification for the treatment of prescription opioid dependence: a pilot study.Physical pain, common psychiatric and substance use disorders, and the non-medical use of prescription analgesics in the United States.Correlates of extramedical use of OxyContin versus other analgesic opioids among the US general population.Prescription opioid aberrant behaviors: a pilot study of sex differences.Toward primary prevention of extra-medical OxyContin® use among young peopleThe diversion and misuse of pharmaceutical stimulants: what do we know and why should we care?Clinical strategies for the primary health care professional to minimize prescription opioid abuse.Evolution of opioid risk management and review of the classwide REMS for extended-release/long-acting opioids.Primary care considerations of the pharmacokinetics and clinical use of extended-release opioids in treating patients with chronic noncancer pain.Characterization of prescription opioid abuse in the United States: focus on route of administration.Would legalizing illicit opioids reduce overdose fatalities? Implications from a natural experiment.Comparison of subjective effects of extended-release versus immediate-release oxycodone/acetaminophen tablets in healthy nondependent recreational users of prescription opioids: a randomized trial.Routes of abuse of prescription opioid analgesics: a review and assessment of the potential impact of abuse-deterrent formulations.Self-limiting non-medical pharmaceutical opioid use among young people in Sydney, Australia: An exploratory study.RGS9-2 Modulates Responses to Oxycodone in Pain-Free and Chronic Pain States.Turning the tide or riptide? The changing opioid epidemic.Correlation of Subjective Effects with Systemic Opioid Exposure from Fixed-Dose Combinations of Oxycodone/Acetaminophen in Recreational Users of Prescription Drugs.Opioid Treatment Agreements Repurposed-But Who Monitors the Monitors?Validity of self-reported misuse of prescription opioid analgesics.Attractiveness of reformulated OxyContin(R) tablets: assessing comparative preferences and tampering potential.Relative preferences in the abuse of immediate-release versus extended-release opioids in a sample of treatment-seeking opioid abusers.Changes in prevalence of prescription opioid abuse after introduction of an abuse-deterrent opioid formulation.The prescription opioid epidemic: a review of qualitative studies on the progression from initial use to abuse.
P2860
Q28396625-50F9A08F-E993-498C-A523-6D624698A43DQ28743202-9EA84A03-74B4-4173-ADD9-0684BF31A061Q33613641-6EF7ABD6-BC8B-4273-B9ED-CA17703C5940Q33761976-9F3DC9AB-4A71-4A7B-8F60-28530C3322C3Q33932344-BDE814DD-F041-40B3-9823-3C6FE4B1778DQ34057971-41B99A28-17E5-4A10-9856-16C0BA9EBE12Q34090634-BF2E7D66-9EFD-4D07-A645-94B980AAFF60Q34859268-7A76BFB5-31D9-48AF-BA98-22CDF275A988Q35052770-F2C1627D-8531-49D5-AEA8-07C2F1664761Q35189633-36949122-7328-47AD-BA2E-A1D1DCD451C1Q35873865-EA564A70-AEC4-4842-9FA8-01887958B4F7Q35893940-7FD67AF7-D9A1-4BC2-B0B6-741F738E2940Q36394777-16321205-D721-429F-9358-AAE1C88EF616Q36549049-BD774786-BC7C-461D-AF74-B256AA5B416EQ36972164-1CCB72CF-A0E4-41BA-A2BC-1E8EAC468B4EQ36980798-DDBBFD7B-F2C2-4279-AC28-41ED5A656F35Q37053718-4FD1E129-47BA-4DB2-802D-B334B51CBC5EQ37098791-295A1AF0-124E-40F5-BE63-F5CF9D3825D1Q37109399-12881DF6-4579-4CF4-876E-5C4609562D48Q37116421-B06F866B-1831-48D9-BA6E-4BB1764E9878Q37408174-5F948F83-6826-4B8E-8642-D62320EFB37CQ37592351-20C60789-AC53-436B-8FC4-157F0241C432Q37982103-039E033D-66D4-4A06-92FE-1CEF1B5DD2A9Q38018218-904E15F7-3CAD-46CD-8EBF-E650ECBB25FBQ38073083-AB74E805-5262-4A23-A039-929F3BEB191EQ38079923-82E04391-0D59-4AFB-B39C-69A2D28E92FDQ38106987-0666BD18-DE91-434C-8C93-2144D8E93F61Q38181184-8D36C460-EC27-480C-8B39-DD1D830863B5Q38241632-4EBDC613-6522-413B-8EB6-7E1CBD088E72Q38632934-C929451E-6EA1-43A7-8FE6-04D98C77D52BQ38895082-A35AFCC9-5711-4407-AECD-DE1DF66BBFD6Q39027669-16B5ED78-2722-4325-96AD-AE040C401D95Q39178248-1CA0411E-CF07-45A0-A449-51BB13AA48BFQ40610091-9C399D82-0D6E-45A7-B39A-981AFB399446Q42025340-D3DC408E-EC15-4034-9F6F-476698A69DD2Q42999550-D7F3FBDC-5545-4901-8838-C9DBC0A9B5C2Q44184161-16C001BB-0A07-4853-BFA4-FA475F9E2ECDQ44339897-A04DD7BA-A4F5-4850-BD05-16A738717BDCQ44342495-9B79EDAE-F017-444C-BCB6-1E3B67EDD840Q47138215-CABFC51B-6660-45A7-9FC9-5D5D14369165
P2860
Prescription OxyContin abuse among patients entering addiction treatment.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Prescription OxyContin abuse among patients entering addiction treatment.
@en
Prescription OxyContin abuse among patients entering addiction treatment.
@nl
type
label
Prescription OxyContin abuse among patients entering addiction treatment.
@en
Prescription OxyContin abuse among patients entering addiction treatment.
@nl
prefLabel
Prescription OxyContin abuse among patients entering addiction treatment.
@en
Prescription OxyContin abuse among patients entering addiction treatment.
@nl
P2093
P2860
P1476
Prescription OxyContin abuse among patients entering addiction treatment.
@en
P2093
A Thomas McLellan
Amy Camilleri
Deni Carise
George E Woody
Karen Leggett Dugosh
Kevin G Lynch
P2860
P304
P356
10.1176/APPI.AJP.2007.07050252
P407
P577
2007-11-01T00:00:00Z